ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
The application of continuous enteral nutrition during sequential chemoradiotherapy and immunotherapy in patients with esophageal cancer: a retrospective study.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePatients with esophageal cancer primarily face nutritional challenges due to swallowing difficulties and gastrointestinal side effects from treatment. This study aimed to evaluate whether, on the basis of sequential chemoradiotherapy combined with immunotherapy (sandwich regimen), proactive continuous nutrition management can improve patients' nutritional status, help maintain host immune homeostasis, reduce treatment-related severe toxicities, and enhance patients' treatment tolerance.
methodsWe performed a single-center retrospective study including 60 esophageal cancer patients treated with sandwich regimen at The Third Affiliated Hospital of Nanjing Medical University from June 2021 to May 2023. Patients were divided into the proactive continuous nutritional management (PCNM) group and the reactive nutritional intervention (RNI) group by different nutritional support strategies during sandwich regimen, and compared pre-post nutritional intervention BMI changes, nutritional risk improvement, immune function, and physical performance status indicators, as well as evaluated the clinical efficacy and safety of the treatment.
resultsAfter intervention, the PCNM group showed significant improvements in BMI and nutritional risk status compared with the RNI group. Meanwhile, the PCNM group exhibited higher CD4+/CD8+ ratio, serum IgG and IgA levels, as well as a lower incidence of malnutrition and radiation esophagitis. Multivariate logistic and linear regression analyses further confirmed that PCNM was an independent protective factor for ameliorating nutritional risk and elevating ΔBMI. No significant intergroup difference was observed in objective tumor treatment efficacy.
conclusionProactive continuous nutritional management improves patients' nutritional status and immune-related laboratory parameters during sequential sandwich therapy.
Indexed as
Identifiers
42377553What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.